发明名称 |
Pyrazole derivatives |
摘要 |
Disclosed are pyrazole compounds of general formula (I), wherein R, R1, Rc, Rd, Re, Rf, X, Y, Z, A and B are as defined in the application. These compounds are active as inhibitors of poly(ADP-ribose)polymerase (PARP) and are useful in methods for treating diseases or conditions mediated by PARP, including breast cancer and malignant melanoma.; |
申请公布号 |
US9249172(B2) |
申请公布日期 |
2016.02.02 |
申请号 |
US201113698548 |
申请日期 |
2011.05.23 |
申请人 |
HANDE PHARMA LIMITED;HANDE STARLAKE BIOSCIENXE CO., LTD. |
发明人 |
Li Chenxi;Shen Weisheng;Fang Yang;Le Xiaoyong |
分类号 |
A61K45/00;A61K38/21;A61K38/46;A61K39/00;C12N9/99;C07H17/02;A61K38/14;A61K38/12;A61K38/07;A61K31/70;A01N43/04;C07D487/04;A61K31/706;A61K45/06;C07D471/04 |
主分类号 |
A61K45/00 |
代理机构 |
Andrews Kurth LLP |
代理人 |
Wang Ping;Andrews Kurth LLP |
主权项 |
1. A compound of general formula (I) or a pharmaceutically acceptable salt thereof: wherein: A and B together with carbons to which A and B attach represent optionally substituted C6-10 aryl, or optionally substituted C3-10 cyclohydrocarbyl; Rc,Rd, Re and Rf are independently selected from hydrogen, optionally substituted C1-6 alkyl and optionally substituted C1-6 acyl; R1 is independently selected from the group consisting of hydrogen, optionally substituted C1-6 alkyl and optionally substituted C1-6 haloalkyl; R is independently selected from the group consisting of hydrogen, optionally substituted C1-6 alkyl, optionally substituted C1-6 haloalkyl, C3-18 heterocyclyl optionally substituted with C1-6 alkyl or C1-6 haloalkyl or C3-12 cycloalkyl, optionally substituted C6-10 aryl, and optionally substituted C7-16 arylalkyl, wherein the heteroatom is selected from the group consisting of nitrogen, oxygen and sulphur; and X represents oxygen or sulphur; Y and Z are independently selected from the group consisting of nitrogen, oxygen, sulphur and optionally substituted methylene, provided that when Y is oxygen or sulphur, then R1 is absent. |
地址 |
Suzhou, Jiangsu Province CN |